Abstract
Background This study seeks to assess the trends in international patient intake over the past decade, with a specific focus on the impact of the COVID-19 pandemic.
Methods This is a retrospective study on the data obtained from SUPREME (CDW Research Search System) of Information Center from a single university hospital. Patient demographics on the gender, age, nationality, and diagnosis visiting International Healthcare Center from January 2013 to June 2023 were collected, and the impact and recovery rates from COVID-19 were calculated in terms of the number of foreign patients. The patient number was further analyzed based on gender, age, nationality, and diagnosis.
Results The impact and recovery rates of COVID-19 on the number of foreign patients was 57% and 71%, respectively. The patients from USA, the old adult group (age 40-64), and patients with cancer were least affected by COVID-19, whereas the patients from the UAE, the young adult group (age 19-39), and patients for medical screening were most affected by COVID-19.
Conclusions The number of international patients steadily was steadily rising since 2013 with a drop in number more than half with the advent of COVID-19 in 2019. However, recent data suggests a revival of this trend, signaling a gradual return to pre-pandemic levels. Despite the overall recovery, future trends are not entirely predictable due to potential factors. Future pandemics, international conflicts, or economic instability could potentially affect the influx of foreign patients. To revive medical tourism, a joint effort from the government and hospital is necessary.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by The Seoul National University Institutional Review Board (IRB number: E-2307-053-1148).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Funding: No funding to disclose
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
